跳至主要内容
临床试验/JPRN-UMIN000030482
JPRN-UMIN000030482已完成1 期

Combination chemotherapy of TS-1, oxaliplatin and irinotecan (TIROX) for unresectable gastric cancer; a phase I study - TIROX for unresectable gastric cancer

Osaka Medical College Hospital0 个研究点目标入组 18 人开始时间: 2017年12月20日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • "(1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy. (2) Recurrence after surgery (3) Past history of severe hypersensitivity to drugs (4) Diarrhea (4 or more times per day or watery diarrhea) (5) Body temperature of over 38 degrees Celsius or active infection (6) serious bone marrow suppression, a renal damage or a liver damage (7) Severe complications (8) Positive HBs antigen (9) Under treatment with flucytosine or atazanavir (10) Under treatment with phenytoin or warfarin (11) Continuous systemic steroid therapy (12) Pregnant women, women with the possibility of the pregnancy, or men who want their partners to become pregnant (13) Psychological disorder (14) Patients judged inappropriate for the study by the physicians "

研究者

发起方
Osaka Medical College Hospital

相似试验

Combination chemotherapy of TS-1, oxaliplatin and... | 临床试验